Publication | Open Access
Efficacy and safety of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional DMARDs in patients with RA at week 97 (SUMMACTA)
122
Citations
11
References
2015
Year
| Year | Citations | |
|---|---|---|
Page 1
Page 1